Denali Therapeutics Inc. DNLI Q2 2025 earnings
Reported August 11, 2025 · Before market open
Revenue-
EPS-$0.72Beat by $0.02
EPS estimate-$0.74
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$2.2M
EPS estimate-$0.54
Financials
Q2 2025Valuation & ratios
Segments
Versus estimates
Diluted EPS
Ask the moment Denali Therapeutics Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI

Claude
Questions, answered.
- When did Denali Therapeutics Inc. report Q2 2025 earnings?
- Denali Therapeutics Inc. (DNLI) reported Q2 2025 earnings on August 11, 2025 before market open.
- What were Denali Therapeutics Inc.'s Q2 2025 revenue and EPS?
- Denali Therapeutics Inc. reported revenue of - and eps of $-0.72 for Q2 2025.
- Did Denali Therapeutics Inc. beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.74 by $0.02.
- How did Denali Therapeutics Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 22.0% from $-0.59.
- Where can I find Denali Therapeutics Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001714899-25-000170) directly on SEC EDGAR. The filing index links above go to sec.gov.